{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:17:24Z","timestamp":1793794644500,"version":"4.6.1"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>We evaluated the accuracy of the 10 \u03bcg desmopressin test in differentiating Cushing disease (CD) from non-neoplastic hypercortisolism (NNH) and ectopic ACTH syndrome (EAS). A systematic review of studies on diagnostic test accuracy in patients with CD, NNH, or EAS subjected to the desmopressin test obtained from LILACS, PubMed, EMBASE, and CENTRAL databases was performed. Two reviewers independently selected the studies, assessed the risk of bias, and extracted the data. Hierarchical and bivariate models on Stata software were used for meta-analytical summaries. The certainty of evidence was measured using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation Working Group) approach. In total, 14 studies were included: 3 studies on differentiated CD versus NNH and 11 studies on differentiated CD versus EAS. Considering \u0394ACTH in 8 studies involving 429 patients, the pooled sensitivity for distinguishing CD from EAS was 0.85 (95% confidence interval [CI]: 0.80\u20130.89, I2 = 17.6%) and specificity was 0.64 (95% CI: 0.49\u20130.76, I2 = 9.46%). Regarding \u0394cortisol in 6 studies involving 233 participants, the sensitivity for distinguishing CD from EAS was 0.81 (95% CI: 0.74\u20130.87, I2 = 7.98%) and specificity was 0.80 (95% CI: 0.61\u20130.91, I2 = 12.89%). The sensitivity and specificity of the combination of \u0394ACTH &amp;gt; 35% and \u0394cortisol &amp;gt; 20% in 5 studies involving 511 participants were 0.88 (95% CI: 0.79\u20130.93, I2 = 35%) and 0.74 (95% CI: 0.55\u20130.87, I2 = 27%), respectively. The pooled sensitivity for distinguishing CD from NNH in 3 studies involving 170 participants was 0.88 (95% CI: 0.79\u20130.93) and the specificity was 0.94 (95% CI: 0.86\u20130.97). Based on the desmopressin test for differentiating CD from EAS, considering \u0394ACTH, \u0394cortisol, or both percent increments, 15%, 19%, or 20% of patients with CD, respectively, would be incorrectly classified as having EAS. For CD versus NNH, 11% of patients with CD would be falsely diagnosed as having NNH, whereas 7% of patients with NNH would be falsely diagnosed as having CD. However, in all hierarchical plots, the prediction intervals were considerably wider than the confidence intervals. This indicates low confidence in the estimated accuracy, and the true accuracy is likely to be different.<\/jats:p><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=85634<\/jats:uri>, identifier CRD42018085634; <jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=68317<\/jats:uri>, identifier CRD42017068317.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1332120","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T04:24:31Z","timestamp":1706588671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Accuracy of the 10 \u03bcg desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Rodrigo Rosa","family":"Giampietro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Vinicius Gama","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizandra Gomes","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Carlos","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania dos Santos","family":"Nunes-Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"bvad087","DOI":"10.1210\/jendso\/bvad087","article-title":"Recognition of nonneoplastic hypercortisolism in the evaluation of patients with Cushing syndrome","volume":"7","author":"Findling","year":"2023","journal-title":"J Endocr Soc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101521","DOI":"10.1016\/j.beem.2021.101521","article-title":"Epidemiology and mortality of Cushing\u2019s syndrome","volume":"35","author":"Hakami","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of cushing\u2019s syndrome","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2527","article-title":"Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health","volume":"90","author":"Ilias","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0946","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: differentiation of pathologic\/neoplastic hypercortisolism (Cushing\u2019s syndrome) from physiologic\/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing\u2019s syndrome)","volume":"176","author":"Findling","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.5.0346","article-title":"The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states","volume":"19","author":"Newell-Price","year":"1998","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1590\/2359-3997000000174","article-title":"Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing\u2019s disease in Brazil","volume":"60","author":"MaChado","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2018.04.017","article-title":"The difficulties of pseudo-Cushing\u2019s syndrome (or \u2018non-neoplastic hypercortisolism\u2019)","volume":"79","author":"Chabre","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-013-0509-x","article-title":"Cushing\u2019s disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review","volume":"17","author":"Lindholm","year":"2014","journal-title":"Pituitary"},{"key":"B10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.beem.2011.07.003","article-title":"Pituitary incidentaloma","volume":"26","author":"Orija","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1542","article-title":"The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up","volume":"91","author":"Isidori","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3943","article-title":"The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing\u2019s disease","volume":"98","author":"Wind","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"CASE21374","DOI":"10.3171\/CASE21374","article-title":"An algorithm to improve lateralization accuracy of inferior petrosal sinus sampling: procedural nuances for complex patterns of venous drainage. Patient series","volume":"2","author":"Matur","year":"2021","journal-title":"J Neurosurg Case Lessons"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02700.x","article-title":"The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"66","author":"MaChado","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2662","article-title":"Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism","volume":"92","author":"Erickson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac686","article-title":"Dynamic testing for differential diagnosis of ACTH-dependent Cushing syndrome: a systematic review and meta-analysis","volume":"108","author":"Ceccato","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0007","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: the role of the desmopressin test in the diagnosis and follow-up of Cushing\u2019s syndrome","volume":"178","author":"Vassiliadi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02113-4","article-title":"Shortage of hCRH for the diagnosis of endogenous CS: the end of an era or the beginning of a new journey","volume":"46","author":"Ceccato","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers-part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J Radiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"ED000163","DOI":"10.1002\/14651858.ED000163","article-title":"Evaluating medical tests: introducing the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy","volume":"7","author":"Bossuyt","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.289637","article-title":"PRISMA-DTA: an extension of PRISMA for reporting of diagnostic test accuracy systematic reviews","volume":"64","author":"Sharifabadi","year":"2018","journal-title":"Clin Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0327","article-title":"Cushing\u2019s syndrome caused by an occult source: difficulties in diagnosis and management","volume":"2","author":"Grossman","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0968","article-title":"Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors","volume":"174","author":"Kamp","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.01.005","article-title":"The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging","volume":"47","author":"Hayes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0985","article-title":"Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome","volume":"93","author":"Batista","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"and QUADAS-2 Group, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/9781119756194.ch10","volume-title":"Undertaking meta-analysis, cochrane handbook for systematic reviews of diagnostic test accuracy","author":"Takwoingi","year":"2023"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.12.021","article-title":"GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables","volume":"122","author":"Schunemann","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.12.020","article-title":"GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy","volume":"122","author":"Schunemann","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500170062035","article-title":"Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states","volume":"269","author":"Yanovski","year":"1993","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0702","article-title":"Differentiating between Cushing\u2019s disease and pseudo-Cushing\u2019s syndrome: comparison of four tests","volume":"170","author":"Alwani","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-102-3-344","article-title":"NIH conference. Clinical applications of corticotropin-releasing factor","volume":"102","author":"Chrousos","year":"1985","journal-title":"Ann Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198605223142101","article-title":"Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing\u2019s disease. Pathophysiologic and diagnostic implications","volume":"314","author":"Gold","year":"1986","journal-title":"N Engl J Med"},{"key":"B37","article-title":"The use of CRF-41 in the differential diagnosis of Cushing\u2019s syndrome and obesity","volume":"16","author":"Grossman","year":"1987","journal-title":"Horm Metab Res Suppl"},{"key":"B38","article-title":"Corticotropin releasing hormone: clinical endocrinology and implications for Cushing\u2019s disease and endogenous depression","volume":"3","author":"Jaeckle","year":"1985","journal-title":"Psychiatr Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0125","article-title":"Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis","volume":"160","author":"Arnaldi","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/cen.12661","article-title":"Evaluation of the DDAVP test in the diagnosis of Cushing\u2019s disease","volume":"82","author":"Rollin","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.6.8964857","article-title":"Cortisol and adrenocorticotropin response to desmopressin in women with Cushing\u2019s disease compared with depressive illness","volume":"81","author":"Malerbi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00830.x","article-title":"Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing\u2019s syndrome and simple obesity","volume":"51","author":"Tsagarakis","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04096.x","article-title":"Corticotrophin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing state: a comparative study","volume":"75","author":"Tirabassi","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302007000800006","article-title":"Pitfalls in the diagnosis of Cushing\u2019s syndrome","volume":"51","author":"Vilar","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302007000400010","article-title":"[Endogenous Cushing\u2019s syndrome: clinical and laboratorial features in 73 cases]","volume":"51","author":"Vilar","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02332","article-title":"The usefulness of combined biochemical tests in the diagnosis of Cushing\u2019s disease with negative pituitary magnetic resonance imaging","volume":"156","author":"Testa","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02278","article-title":"Ectopic ACTH syndrome: our experience with 25 cases","volume":"155","author":"Salgado","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K08E-353","article-title":"Evaluation of diagnostic tests for ACTH-dependent Cushing\u2019s syndrome","volume":"56","author":"Suda","year":"2009","journal-title":"Endocr J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.44.687","article-title":"Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"44","author":"Sakai","year":"1997","journal-title":"Endocr J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2000.00676.x","article-title":"Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing\u2019s syndrome","volume":"247","author":"Coiro","year":"2000","journal-title":"J Intern Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.10.6862","article-title":"The desmopressin test in the differential diagnosis between Cushing\u2019s disease and pseudo-Cushing states","volume":"85","author":"Moro","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1146","article-title":"Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing\u2019s disease","volume":"95","author":"Tirabassi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02717.x","article-title":"The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing\u2019s syndrome from pseudo-Cushing\u2019s states","volume":"66","author":"Pecori Giraldi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01695-1","article-title":"Indication to dynamic and invasive testing in Cushing\u2019s disease according to different neuroradiological findings","volume":"45","author":"Ferrante","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa409","article-title":"Non-invasive diagnostic strategy in ACTH-dependent Cushing\u2019s syndrome","volume":"105","author":"Frete","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ20-0837","article-title":"The usefulness of the combined high-dose dexamethasone suppression test and desmopressin stimulation test in establishing the source of ACTH secretion in acth-dependent Cushing\u2019s syndrome","volume":"68","author":"Qiao","year":"2021","journal-title":"Endocr J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0729-y","article-title":"Second-line tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"19","author":"Barbot","year":"2016","journal-title":"Pituitary"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.1330954.x","article-title":"Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess","volume":"46","author":"Colombo","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00341.x","article-title":"The desmopressin stimulation test in the differential diagnosis of Cushing\u2019s syndrome","volume":"38","author":"Malerbi","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.14310\/horm.2002.1204","article-title":"The response of corticotropin and adrenal steroids to desmopressin stimulation in patients with various forms of hypercortisolism","volume":"7","author":"Marova","year":"2008","journal-title":"Hormones (Athens)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.1.3674","article-title":"A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing\u2019s syndrome","volume":"82","author":"Newell-Price","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01260.x","article-title":"The limited value of the desmopressin test in the diagnostic approach to Cushing\u2019s syndrome","volume":"54","author":"Terzolo","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8358","article-title":"The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion","volume":"87","author":"Tsagarakis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345640","article-title":"The role of non-invasive dynamic tests in the diagnosis of Cushing\u2019s syndrome","volume":"31","author":"Vilar","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.athoracsur.2004.09.040","article-title":"Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests","volume":"79","author":"Jones","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta9120","article-title":"A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy","volume":"9","author":"Dinnes","year":"2005","journal-title":"Health Technol Assess"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8357","article-title":"Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing\u2019s syndrome","volume":"87","author":"Newell-Price","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","article-title":"A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing\u2019s syndrome","volume":"77","author":"Nieman","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad454","article-title":"Ovine CRH stimulation and 8 mg dexamethasone suppression tests in 323 patients with ACTH-dependent Cushing\u2019s syndrome","volume":"109","author":"Elenius","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4158\/EP11179.OR","article-title":"Assessment of the utility of the high-dose dexamethasone suppression test in confirming the diagnosis of Cushing disease","volume":"18","author":"Aytug","year":"2012","journal-title":"Endocr Pract"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.6.1780","article-title":"Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing\u2019s syndrome","volume":"82","author":"Aron","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90113-3","article-title":"The corticotropin-releasing-hormone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing\u2019s syndrome","volume":"2","author":"Hermus","year":"1986","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-104-2-180","article-title":"An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing\u2019s syndrome","volume":"104","author":"Tyrrell","year":"1986","journal-title":"Ann Intern Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/j.1365-2265.1986.tb01667.x","article-title":"Diagnosis and management of ACTH-dependent Cushing\u2019s syndrome: comparison of the features in ectopic and pituitary ACTH production","volume":"24","author":"Howlett","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02099-z","article-title":"Second-line tests in the differential diagnosis of neoplastic and non-neoplastic hypercortisolism: a systematic review and meta-analysis","volume":"46","author":"Mondin","year":"2023","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1332120\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T04:24:41Z","timestamp":1706588681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1332120\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":77,"alternative-id":["10.3389\/fendo.2024.1332120"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1332120","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"article-number":"1332120"}}